Israel hosts board-certified specialists focusing on advanced and metastatic prostate cancer, including experts like Prof. David Sarid and Prof. Haim Matskin. These doctors lead multidisciplinary teams at JCI-accredited centers, using systemic therapies and clinical trials to treat complex, spreading disease.
- Specialized leadership. Prof. David Sarid leads uro-oncology at Sourasky, specializing in systemic treatments for advanced cases.
- Advanced therapies. Prof. Haim Matskin pioneered brachytherapy and cryotherapy, which use radiation or cold to treat tumors.
- Surgical precision. Prof. Jack Baniel performs robotic nerve-sparing surgeries to preserve function during complex cancer removals.
- Research access. Dr. Viktoriya Nejman heads clinical studies, providing patients access to new experimental cancer therapies.
Bookimed Expert Insight: Patients with metastatic disease benefit from choosing doctors who lead dedicated uro-oncology departments rather than general urology units. Specialists like Prof. Mario Sofer and Prof. David Sarid at Sourasky emphasize integrated care, which is vital when combining surgery with advanced systemic treatments.
Patient Consensus: Patients emphasize the need for early oncology referrals and suggest choosing centers where urology and radiation oncology are on-site. Many found that preparing detailed questions helped them take an active role in managing their advanced treatment plans.
